Literature DB >> 11303778

VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress.

R A Steingart1, B Solomon, D E Brenneman, M Fridkin, I Gozes.   

Abstract

Oxidative stress is a common associative mechanism that is part of the pathogenesis of many neurodegenerative diseases. Vasoactive intestinal peptide (VIP) is a principal neuropeptide associated with normal development and aging. We have previously reported that VIP induced the secretion of proteins from glial cells, including the novel survival-promoter: activity-dependent neurotrophic factor (ADNF). ADNF-9, a nine amino acid peptide derived from ADNF, protects neurons from death caused by various toxins. In the present study, we examined the neuroprotective effect of VIP against oxidative stress in a pheochromocytoma cell line (PC12). In addition, a lipophilic derivative of VIP, Stearyl-Nle17-VIP (SNV), and two femtomolar-acting peptides: ADNF-9 and a 70% homologous peptide to ADNF-9, NAP were tested as well. PC12 cells were treated with 100 microM H2O2 for 24 h resulting in a reduction in cell survival to 35-50% as compared to controls. Addition of VIP or SNV prior and during the exposure to100 microM H2O2 increased cell survival to 80-90% of control values. Culture treatment with ADNF-9 or NAP in the presence of 100 microM H2O2 increased cell survival to 75-80% of control values. Messenger RNA expression analysis revealed that incubation with VIP resulted in a twofold increase in VIP mRNA, whereas NAP treatment did not cause any change in VIP expression, implicating different mechanisms of action. Furthermore, addition of an ADNF-9 antibody prevented the ability of VIP to protect against oxidative stress, suggesting that VIP protection is partially mediated via an ADNF-like protein.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11303778     DOI: 10.1385/JMN:15:3:137

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  45 in total

1.  Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides.

Authors:  D E Brenneman; J Hauser; E Neale; S Rubinraut; M Fridkin; A Davidson; I Gozes
Journal:  J Pharmacol Exp Ther       Date:  1998-05       Impact factor: 4.030

2.  Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury.

Authors:  K Z Guyton; Y Liu; M Gorospe; Q Xu; N J Holbrook
Journal:  J Biol Chem       Date:  1996-02-23       Impact factor: 5.157

3.  Neurotrophic factors [activity-dependent neurotrophic factor (ADNF) and basic fibroblast growth factor (bFGF)] interrupt excitotoxic neurodegenerative cascades promoted by a PS1 mutation.

Authors:  Q Guo; L Sebastian; B L Sopher; M W Miller; G W Glazner; C B Ware; G M Martin; M P Mattson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

Review 4.  A scientific rationale for protective therapy in Parkinson's disease.

Authors:  C W Olanow
Journal:  J Neural Transm Gen Sect       Date:  1993

5.  Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease.

Authors:  D Offen; Y Sherki; E Melamed; M Fridkin; D E Brenneman; I Gozes
Journal:  Brain Res       Date:  2000-01-31       Impact factor: 3.252

Review 6.  A novel signaling molecule for neuropeptide action: activity-dependent neuroprotective protein.

Authors:  I Gozes; M Bassan; R Zamostiano; A Pinhasov; A Davidson; E Giladi; O Perl; G W Glazner; D E Brenneman
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

7.  A femtomolar-acting neuroprotective peptide induces increased levels of heat shock protein 60 in rat cortical neurons: a potential neuroprotective mechanism.

Authors:  R Zamostiano; A Pinhasov; M Bassan; O Perl; R A Steingart; R Atlas; D E Brenneman; I Gozes
Journal:  Neurosci Lett       Date:  1999-04-02       Impact factor: 3.046

8.  Vasoactive intestinal peptide but not galanin promotes survival of neonatal rat sympathetic neurons and neurite outgrowth of PC12 cells.

Authors:  L Klimaschewski; K Unsicker; C Heym
Journal:  Neurosci Lett       Date:  1995-08-04       Impact factor: 3.046

9.  Stearyl-norleucine-vasoactive intestinal peptide (VIP): a novel VIP analog for noninvasive impotence treatment.

Authors:  I Gozes; A Reshef; D Salah; S Rubinraut; M Fridkin
Journal:  Endocrinology       Date:  1994-05       Impact factor: 4.736

10.  Vasoactive intestinal peptide gene expression in the rat pheochromocytoma cell line PC12.

Authors:  T Tsukada; M Fukushima; H Takebe; Y Nakai
Journal:  Mol Cell Endocrinol       Date:  1995-02       Impact factor: 4.102

View more
  20 in total

1.  Alzheimer's disease: my point of view.

Authors:  I Gozes
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

2.  NAP accelerates the performance of normal rats in the water maze.

Authors:  Illana Gozes; Roy Alcalay; Eliezer Giladi; Albert Pinhasov; Sharon Furman; Douglas E Brenneman
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

Review 3.  Microtubule-Tau Interaction as a Therapeutic Target for Alzheimer's Disease.

Authors:  Yanina Ivashko Pachima; Liu-yao Zhou; Peng Lei; Illana Gozes
Journal:  J Mol Neurosci       Date:  2016-02       Impact factor: 3.444

4.  Parkinson's and Alzheimer's diseases: protein aggregations and neuroprotection.

Authors:  Illana Gozes
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

5.  Activity-dependent neurotrophic factor-9 and NAP promote neurite outgrowth in rat hippocampal and cortical cultures.

Authors:  Virginia L Smith-Swintosky; Illana Gozes; Douglas E Brenneman; Michael R D'Andrea; Carlos R Plata-Salaman
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

6.  VIP, from gene to behavior and back: summarizing my 25 years of research.

Authors:  Illana Gozes
Journal:  J Mol Neurosci       Date:  2008-07-08       Impact factor: 3.444

7.  Experimental methods for testing the effects of neurotrophic peptide, ADNF-9, against alcohol-induced apoptosis during pregnancy in c57bl/6 mice.

Authors:  Youssef Sari
Journal:  J Vis Exp       Date:  2013-04-24       Impact factor: 1.355

8.  VIP-Related protection against lodoacetate toxicity in pheochromocytoma (PC12) cells: a model for ischemic/hypoxic injury.

Authors:  E Sigalov; M Fridkin; D E Brenneman; I Gozes
Journal:  J Mol Neurosci       Date:  2000-12       Impact factor: 3.444

9.  NAP mechanisms of neuroprotection.

Authors:  Illana Gozes; Ruth A Steingart; Avron D Spier
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

10.  Protein profiling reveals antioxidant and signaling activities of NAP (Davunetide) in rodent hippocampus exposed to hypobaric hypoxia.

Authors:  Niroj Kumar Sethy; Narendra Kumar Sharma; Mainak Das; Kalpana Bhargava
Journal:  J Mol Neurosci       Date:  2014-07-20       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.